Back
Organogenesis Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
59
ORGO
Organogenesis Holdings
Last Price:
2.74
Seasonality Move:
-10.44%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.12
Seasonality Move:
-0.33%
Buy
59
Organogenesis Holdings (ORGO)
is a Buy
Is Organogenesis Holdings a Buy, Sell or Hold?
- The current Organogenesis Holdings [ORGO] share price is $2.74. The Score for ORGO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ORGO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.12. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ORGO Stock Price Chart
What is Organogenesis Holdings's stock price today?
-
The Organogenesis Holdings share price today is $2.74
The current trend is relatively stagnant and ORGO is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
ORGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 50.67 | Buy |
| Chaikin Money Flow: | -199037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.42 - 2.94) | Buy |
| Bollinger Bands (100): | (2.65 - 3.73) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 66.72 | Buy |
| Chaikin Money Flow: | -109706734 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.1) | Buy |
| Bollinger Bands (100): | (0.09 - 0.17) | Sell |
ORGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.75 | Sell |
| 20-day SMA: | 2.63 | Buy |
| 50-day SMA: | 2.75 | Sell |
| 200-day SMA: | 2.97 | Sell |
| 8-day EMA: | 2.76 | Sell |
| 20-day EMA: | 2.71 | Buy |
| 50-day EMA: | 2.81 | Sell |
| 200-day EMA: | 3.06 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.1 | Buy |
| 20-day SMA: | 0.09 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.28 | Sell |
| 8-day EMA: | 0.1 | Buy |
| 20-day EMA: | 0.09 | Buy |
| 50-day EMA: | 0.11 | Buy |
| 200-day EMA: | 0.5 | Sell |
Organogenesis Holdings Earnings Growth & ORGO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.05 per share, and an increase next year of $0.10 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Organogenesis Holdings Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||